Cancer - Fog Pharmaceuticals, Inc.
Cancer
Status:
Active, open to accrualClinicalTrials.gov:
NCT05919264A Phase 1/2 Study of FOG-001 in Participants with Locally Advanced or Metastatic Solid Tumors
A Phase 1/2 Study of FOG-001 in Participants with Locally Advanced or Metastatic Solid Tumors